NCT07380295Recruiting
Improving Workforce Participation and Well-Being in Individuals With Multiple Sclerosis - A Feasability Study
Improving Workforce Participation and Well-Being in Individuals With Multiple Sclerosis- A Feasability Study
Source: ClinicalTrials.gov · Last updated 2 Feb 2026
Brief summary (registry, in English)
Multiple sclerosis (MS) is a chronic neurodegenerative disease and a leading cause of reduced workforce participation due to neurological illness in Western countries. Over the past 30 years, new treatments have reduced symptom burden, allowing patients to stay in the workforce longer. However, fatigue and cognitive impairments remain major barriers to work capacity. This project aims to preliminary examine the impact of cognitive function on work ability, and assess the role of neuropsychologists in multidisciplinary rehabilitation teams. It consists of a feasibility study evaluating the integration of neuropsychological interventions into teambased work-oriented rehabilitation. The specific research questions are: 1. How can neuropsychological interventions be integrated into team-based work-oriented rehabilitation? 2. How do these interventions relate to work ability and well-being in individuals with MS? The investigators plan to collect data on 20 consecutively patients with MS before, 6 months after and 2 years after a neuropsychological testing and intervention. The patients are being followed on measures related to well-being and work ability. Data from the neuropsychological assessment, other rehabilitation interventions as well as data related to treatment and progress of MS are also collected. Our findings aim to enhance work-oriented rehabilitation and provide a deeper understanding of how to support individuals with MS in maintaining employment and overall well-being
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 20 (estimated)
- First submitted
- 22 Sept 2025
- Start date
- 22 Jul 2025
- Primary completion date
- Sept 2028
- Lead sponsor
- Region Gävleborg
- Diseases
- Multiple sclerosis
- NCT number
- NCT07380295
What you commit to
- Study type: Observational
- Planned participants: 20
- From 22 Jul 2025 to the primary completion date, Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Other diagnosis hindering work participation more than MS
- \-
Who the study is looking for
- Multiple sclerosis Age between 18-65 Refered to neuropsychological assessment at the Neurology departement at Gävle Hospital -
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Gävle Hospital Coordinator of this site? Confirm its status | Gävle | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.